The Government is pursuing partnership with local manufacturers for contract manufacturing of HIV related commodities including ARVs to ensure sufficient supply of the commodities.
Speaking at Afya House when she received a donation of 1800 packs of TLD Anti-Retro-Virals drugs( ARVs), from Universal Corporations Limited, Health Principal Secretary Susan Mochache noted that the challenges experienced in HIV prevention, care, and treatment services in the recent past partly attributable to emergence of the COVID-19 pandemic and the ever-increasing burden of non-communicable diseases calls for self-sufficiency in commodities for strategic health programs.
The PS said that the Ministry of Health has prioritized optimization of ARV regimens to ensure people living with HIV receive the best medicine available in the most efficient and cost-effective way.
“The Ministry has also increased allocated funds annually for procurement of HIV commodities. In addition, we are investing in research and innovation to facilitate evidence based and focused interventions which will accelerate achievement of Universal Health Coverage.” She said.
The donation comes in the Week when Kenya joins the rest of the World on 1st December 2021 to mark the World Aids Day to be graced by H.E. President Uhuru Kenyatta in Nakuru County.
Distributed by APO Group on behalf of Ministry of Health, Kenya.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
